Cargando…
Targeting IRF3 as a YAP agonist therapy against gastric cancer
The Hippo pathway plays a vital role in tissue homeostasis and tumorigenesis. The transcription factor IRF3 is essential for innate antiviral immunity. In this study, we discovered IRF3 as an agonist of Yes-associated protein (YAP). The expression of IRF3 is positively correlated with that of YAP an...
Autores principales: | Jiao, Shi, Guan, Jingmin, Chen, Min, Wang, Wenjia, Li, Chuanchuan, Wang, Yugong, Cheng, Yunfeng, Zhou, Zhaocai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789414/ https://www.ncbi.nlm.nih.gov/pubmed/29339449 http://dx.doi.org/10.1084/jem.20171116 |
Ejemplares similares
-
MST4 kinase suppresses gastric tumorigenesis by limiting YAP activation via a non-canonical pathway
por: An, Liwei, et al.
Publicado: (2020) -
The antineoplastic drug metformin downregulates YAP by interfering with IRF-1 binding to the YAP promoter in NSCLC
por: Jin, Dan, et al.
Publicado: (2018) -
A YAP/TAZ-CD54 axis is required for CXCR2(−)CD44(−) tumor-specific neutrophils to suppress gastric cancer
por: Nie, Pingping, et al.
Publicado: (2022) -
VGLL4 targets a TCF4–TEAD4 complex to coregulate Wnt and Hippo signalling in colorectal cancer
por: Jiao, Shi, et al.
Publicado: (2017) -
MCM6 is a critical transcriptional target of YAP to promote gastric tumorigenesis and serves as a therapeutic target
por: Wang, Yifei, et al.
Publicado: (2022)